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Spinal cord injury (SCI) is typically a traumatic event that impacts a patient's 
physical, psychological, and social well-being by damaging motor and sensory neurons 
and altering autonomic function leading to cardiac remodeling (42). Spinal cord injuries are 
based on a scale of severity, with severe, high-level lesions strongly correlating to the 
degree of cardiovascular dysfunction. (30)(37)(41). The decline in cardiovascular function is 
prevalent after high thoracic SCI, with patients suffering from daily bouts of orthostatic 
hypotension (OH) and autonomic dysreflexia (AD), both of which prevent and delay 
rehabilitation efforts and lessen quality of life after injury (28)(30). Past studies have 
demonstrated robust cardiomyocyte remodeling and subsequent cardiovascular demise 
in completely transected rodent models of SCI (42)(43). This study provides more insight 
into the incidence of cardiomyocyte remodeling and LV atrophy following clinically-














LIST OF FIGURES 
FIGURE                                                                                                                    PAGE 
 
1. Comparison of cardiomyocyte morphology in T2 contusion and uninjured control 
rodents in the left ventricle, right ventricle, and interventricular septum………...16 
2. Comparison of cardiomyocyte shapefactor in T2 contusion and uninjured control 


















INTRODUCTION AND SIGNIFICANCE 
Spinal cord injury (SCI) is a devastating neurological condition affecting nearly 5.4 
million individuals in the United States (27). In addition to damaging motor and sensory 
circuitry within the spinal cord (SC), pathways of the autonomic nervous system (ANS) 
are also disrupted leading to the loss of cardiovascular (CV) homeostasis, or equilibrium. 
(14)(30). The degree of CV dysfunction is strongly correlated with both the severity and the 
SC level of the lesion, with higher and more severe injuries resulting in more profound 
impairment of metabolic, physiological, and psychological processes (30)(37)(41). As such, 
high thoracic level (T1-T5) SCI patients have an elevated risk of developing 
cardiovascular disease (CVD) (37)(41)(42) and stroke (41). Patients also suffer from daily bouts 
of orthostatic hypotension (OH) and autonomic dysreflexia (AD), both of which prevent 
and delay rehabilitation efforts and lessen quality of life after injury (28)(30). Reasons for the 
decline in CV function are due to a number of factors; and involve the increase in 
sedentary lifestyles (33)(43) due to paralysis, morphological changes in autonomic 
sympathetic pre-ganglionic neurons, (SPGN) (43) and structural changes in CV end-
organs (the heart and vasculature) following high-level, severe SCI (44). 
Completeness of the lesion has profound ramifications on the resulting functional 
status of SCI individuals. Severe, anatomically complete injuries convey a full loss of 
motor and sensory functions below the lesion, whereas incomplete contusion injuries 
result in a partial preservation of SC circuitry and function (25). Most published studies 
examining the link between CV dysfunction following high-thoracic SCI and cardiac 
remodeling have done so using experimental models of complete injury (complete 




and patients experience a wide array of CV symptoms and dysfunction (25).  In a study 
completed by Squair et al. (2018) (37), it was determined that SCI-induced cardiomyocyte 
atrophy was severity-dependent, with cardiac remodeling and the resulting impairment 
in LV function only affecting severely-injured rodents (37). However, experimental groups 
used in this study were small and it was unknown if the same findings can be replicated 
in other clinically-relevant injury severity models in which hindlimb locomotor function, 
and thus venous return to the heart, is only partially altered.  
Normal function of the CV system relies on both proper cardiac activity and 
appropriate responses in peripheral vasculature to changes in systemic pressure (43). The 
heart and vasculature are regulated by the ANS to ensure adequate perfusion during 
various physiological conditions (17). Cardiac SPGNs that stimulate myocardium to 
increase contractility during times of stress reside in the intermediolateral gray column of 
the SC from thoracic vertebrae T1-T5 (43). Sympathetic pre-ganglionic neurons are thus 
directly impacted by high-level SCI, and likely contribute to the CV dysfunction 
experienced by patients (41). 
Orthostatic hypotension (OH) is a condition that is common in patients with cervical 
and high thoracic SCI (15). Orthostatic hypotension can be described as an overall drop in 
baseline arterial blood pressure (BP) and slow heart rate (HR) following positional 
changes (32). Reduced skeletal muscle pump activity and blood pooling in vasculature 
beds below the lesion in conjunction with reduced sympathetic modulation of vascular 
tone is responsible for episodes of OH and ultimately results in reduced venous return to 
the heart (19). Orthostatic hypotension is a cardinal sign of autonomic dysfunction and is 




decreases in systolic BP have been shown to be associated with cardiac remodeling and 
cardiac decline (2). 
Cardiac remodeling describes the molecular, cellular, and interstitial changes that 
manifest as changes in size, shape, and function of the heart after injury (20). Cardiac 
remodeling is closely associated with HF (7)(20)(43), as the clinical manifestations of HF 
are the result of changes to the heart’s cellular and molecular components and 
mediators that drive homeostatic control (43). Cardiomyocyte atrophy progression after 
SCI may be due to a variety of factors, but ultimately leads to decreased left ventricle 
(LV) size and attenuated pumping efficiency (37).  
The clinical diagnosis of cardiac remodeling involves the detection of 
morphological changes of the cardiomyocyte (3). The cardiomyocyte is the most 
physically energetic cell in the body (32). They are connected end-to-end by gap 
junctions, which allow concerted contractile activity. The contraction-relaxation cycle is 
controlled by the cyclic increase and decrease of calcium, initiated by depolarization of 
the sarcolemma, and sustained by the calcium reuptake and release by the 
sarcoplasmic reticulum. Cardiomyocyte health is dependent upon adequate physical 
activity and CV activation (3)(7).  Following SCI, the paralysis-induced sedentarism does 
not support healthy CV function, as high-lesion SCI patients present with reduced 
venous return, impaired sympathetic modulation of the myocardium, hypotension, and 
the general lack of BP control during normal, daily activities (32)(44). Research has shown 
that following severe high-level SCI, in which resting BP is drastically reduced, (37) there 
is a decrease in cardiomyocyte length, Z-disc width, and fewer sarcomeres in the 




strongly correlated with reduced stroke volume (SV) and efficiency of the cardiac cycle, 
(37) and likely contribute to the decrease in cardiac function and incidence of CVD after 
SCI. Recent studies have shown that passive hind-limb cycling and staying active helps 
to prevent or completely reverse cardiomyocyte atrophy (41). Other studies show how the 
use of dobutamine helps normalize sympathetic output in rodents helping to reverse the 
negative effects of pressure-derived complications (20)(25). 
While there has been a great deal of SCI research focused on improving 
locomotor function after injury, CVD remains the number one cause of morbidity and 
mortality for individuals living with chronic, high-thoracic SCI (28)(33). Understanding how 
cardiac remodeling contributes to the decline in CV function, and whether changes in 
cardiomyocyte structure and function contribute to episodes of OH and AD is of utmost 
importance for the SCI community (16). Therefore, we have performed a set of 
experiments examining the incidence of LV atrophy and cardiomyocyte remodeling in 













We hypothesized that cardiomyocyte atrophy after SCI will be similar to what has 
been published previously (37). We expected to find that rodents receiving severe T2 
contusion injuries will have robust cardiac remodeling, including changes in 
cardiomyocyte shape and size and reduced presence of sarcomeres as compared to 
uninjured control animals. Combined with reduced locomotor function due to incomplete 
paralysis below the lesion and the attenuated sympathetic modulation of CV end-
organs, atrophy of cardiomyocytes and the subsequent loss of LV mass will lead to 











MATERIALS AND METHODS 
         Female Sprague Dawley rats were used to complete these studies. Rats were 
randomly divided into two groups: Uninjured Control (CON, n=3) and Severe 35 g/cm T2 
SCI (T2-SCI, n=6). Contusion injuries were delivered using the NYU Impactor (Mascis, 
Rutgers University). Rodents were double housed in tiny cages (7.5” x 8.5”, total floor 
area = 64”) to restrict locomotion. Eight weeks after injury, terminal immunohistochemistry 
staining and inverse microscopic techniques were performed to study the presence and 
extent of cardiomyocyte atrophy. 
  
Cardiomyocyte Immunohistochemistry: To assess structural remodeling of 
cardiomyocytes following SCI, animals were trans-aortically perfused with phosphate 
buffer solution and the hearts were excised for immunohistochemical analysis. Following 
explanation, hearts were weighed, and submersion fixated with 10% neutral formalin 
solution for 48 hours. Hearts were then transversely divided into five 3mm sections, 
paraffin-embedded, and sectioned at 4µm intervals for staining. Actin (alpha-Sarcomeric) 
antibody staining was performed on the slides to help quantify the data via inverse 
microscopic techniques (39). The slides were heated at 80°C for 30 minutes, and then 
placed in xylene to deparaffinize. Stepwise rehydration steps were implemented with 
decreasing concentrations of ethanol (100, 95, 95, 90, 80%) prior to being placed in water. 
The slide had all antigens exposed by immersing slides in citrate buffer (2.4g/L Sodium 
Citrate Tribasic Dehydrate, 0.35g/L Citric Acid, pH 6.0) overnight for 18-20 hours at room 
temperature. The citrate buffer is used to act as an antigen retrieval treatment step. The 
following day, slides were removed from citrate buffer, washed in water, and incubated in 




Rhodamine (1:50 dilution, in Invitrogen Antibody Diluent Reagent) for 30 minutes to stain 
red fluorescence. Next, slides were washed with 1x KPBS (3 times, 3 min each) followed 
by incubation in a dark hydration chamber in the reagent alpha-Sarcomeric Actin (1:500 
dilution, in Invitrogen Antibody Diluent Reagen) to stain for blue fluorescence. 
Simultaneously, the IgM negative control (1:500 dilution) of alpha-Sarcomeric Actin in 
Invitrogen Antibody Diluent Reagent were applied for 1 hour, and then washed with 1x 
KPBS (4 times, 3 min each). Finally, the reagent Alexa-Flour 488 anti-mouse IgM, staining 
actin, were utilized on each slide with a 1:750 dilution in Invitrogen Antibody Diluent 
Reagent and sudan black (200µl per slide) was applied to slides to mitigate 
autofluorescence signal. Slides were incubated in a dark hydration chamber for 15 
minutes, washed 1x KPBS (6 times, 3 min each), rinsed in water (1 time, 3 min), and 
coversliped with Fluoromount G. All slides were stored at 4° C and were allowed to dry 
for 24 hours before imaging. 
  
Imaging and Quantification of Cardiomyocytes: To quantify structural remodeling of 
cardiomyocytes after SCI, heart sections were imaged using an inverted microscope 
(20x). Non-biased images of the LV, right ventricle (RV), and interventricular septum (IS) 
(20, 10, 7 images per sample, respectively) were taken from each slide and analyzed for 
circular cardiomyocytes, disregarding longitudinal sections. The imaging program NIS-
Elements and analysis program NIS-Elements Analysis determined whether or not the 
cardiomyocytes were deemed circular, or 0.895 – 1 mm. Anything below 0.895 mm was 
not included due to being an insufficient shape. Using NIS-Elements Analysis, the severity 
of the cardiomyocyte atrophy was calculated. Significance of cardiomyocyte atrophy was 




data was collected from each sample using NIS-Elements Analysis, a mathematical 
mean, maximum, and minimum of cardiomyocyte area and shapefactor was calculated 
for each region of the heart in T2-SCI and CON animals.  
 
Statistical Analysis: Between-group differences for working heart assessments were 
analyzed using an independent repeated measures ANOVA. A standard deviation outlier 
calculation was implemented using two criteria. 1) data was considered to be an outlier if 
it was ≥ 3 standard deviations outside from the calculated mean. 2) data was considered 
to be an outlier after the second outlier calculation if it remained ≥ 2.5 standard deviations 
from the calculated mean. A Post Hoc test was implemented using Tukey HSD. 
Correlations between cardiomyocyte area and shapefactor in LV, RV, and IS have been 
statistically analyzed. The mathematical mean was calculated in each sample, LV, RV, 
and IS, of both groups, T2-SCI and CON, and XY graphs were made to help convey 
correlations. Data was presented as a mean +/- standard deviation (SD), unless otherwise 














Cardiac tissue was stained, imaged, and analyzed to compare cardiomyocyte 
morphology T2-SCI and CON. Myocardial tissue was stained with antibodies such as 
Wheat Germ Agglutinin (WGA)-Rhodamine (ECM; red), alpha-Sarcomeric actin 
(cardiomyocytes; green), and counterstained with DAPI (nuclei; blue). All channels were 
merged to convey the best visual representation and convey an example of cardiac 
tissue that was analyzed. Representative images of cardiomyocyte morphology in the 
LV, RV, and IS are shown for T2-SCI and CON in Figure 1A and 1B, respectively. The 
cross-sectional area of cardiomyocytes for T2-SCI and CON were determined for the 
LV, RV, and IS (Figure 1C). The graphs represent mean area, maximum area, and 
minimum area of each sample (1Ci, 1Cii, 1Ciii, respectively). There were no significant 
differences between T2-SCI and CON groups for any of the variables measured. A 
magnified image of the cross-sectional area in myocardial tissue conveys a visual 
representation of various sizes and shapes of cardiomyocytes (Figure 1D). The arrow 
drawn provides an example of a cardiomyocyte that fit the criteria, and therefore was a 
data point of sample LV and group T2-SCI throughout analysis.   
Cardiomyocyte morphology, was also analyzed in terms of shapefactor, as shown 
in Figure 2. The graphs represent mean shapefactor, maximum shapefactor, and 
minimum shapefactor. There were no significant differences between T2-SCI and CON 
groups. However, in Figure 2, image 1Ai, cardiomyocyte shapefactor RV mean 
approached significance, p = 0.053, between groups, T2-SCI and CON.  
Although no significant differences between T2-SCI and CON groups were found, 




studies (34). Some of the correlations found were that all samples, LV, IS, and RV, in 
groups, T2-SCI and CON, represented direct relationships in mean shape. The 
correlations involving area RV mean in CON, indicated inverse relationships with both 
shape RV mean and area IS mean. The last correlation found in CON, indicated an 
inverse relationship between area and shape LV mean. Other correlations found in group 
















Figure 1. Cardiomyocyte morphology in T2 SCI and CON in LV, RV, 
and IS. Image A and B depicts representative images of cardiomyocyte 
morphology after T2-SCI and CON, respectively.  Cardiomyocyte area was 
calculated and reported for T2-SCI vs CON in the LV, RV, and IS. Data is 
reported as mean, maximum, and minimum cross-sectional myocyte areas 
(Image 1Ci, 1Cii, and 1Ciii respectively). Image D conveys a 
representative myocardial tissue section that is stained with antibodies 
such as Wheat Germ Agglutinin (WGA)-Rhodamine (ECM; red), alpha-
Sarcomeric actin (cardiomyocytes; green), and counterstained with DAPI 
















Figure 2. Shapefactor morphology after T2 contusion vs uninjured control in LV, 
RV, IS. The shapefactor graphs conveys the correlations between cardiomyocyte 
shape, including the minimum and maximum of each group, T2 SCI and CON, in LV, 














While there has been a great deal of SCI research focused on improving 
locomotor function after injury, there is limited data on cardiomyocyte morphology after 
SCI (28)(33). This study mimics clinically-relevant thoracic vertebra, T2, contusions to 
expand the data on CV morphology after SCI. The majority of previous studies utilized 
completely transected SC models, which do not anatomically match the majority of 
clinical SCI (37)(42). More than 65% of all clinical SCIs are anatomically incomplete and 
patients present with a functional gradient of locomotion, sensory, and autonomic 
phenotypes (17)(39). Luckily, SCI treatment and management have improved over the last 
few decades (35). But, as patients are living longer, the incidence of life-threatening 
secondary complications is increasing. As such, CVD has become one of the leading 
causes of morbidity and mortality in chronic, high-level SCI patients (37)(41).  Despite this, 
studies examining the link between SCI, loss of locomotor function, and the 
development of CVD are fairly recent. Further, the majority of published work has 
focused on the severe clinical manifestations of CV decline following complete, high-
level lesions, such as OH and AD (28)(30). Little research has been performed to 
understand the morphological and molecular changes in the heart tissue itself after 
injury. 
This study hypothesized that rodents receiving severe T2-SCI will have robust 
cardiac remodeling, including changes in cardiomyocyte shape and size and reduced 
presence of sarcomeres, or functional unit of striated muscle, as compared to CON 
animals. Although we did not find significant differences in cardiomyocyte morphology 




extrapolation of important findings. The CV system is, in part, regulated physiologically 
by the two divisions of the ANS: the sympathetic nervous system (SNS) and 
parasympathetic nervous system (PNS). Working in tandem, the SNS and PNS utilize 
effector molecules such as norepinephrine (NE) and acetylcholine to regulate and 
maintain CV homeostasis (23). The SPGNs that modulate cardiac function are located in 
the intermediolateral cell column of the SC gray matter from T1-T5 (23)(41); 
parasympathetic preganglionic neurons are located in the brainstem (43). Following high-
thoracic SCI, portions of the SC circuitry responsible for sympathetic modulation of CV 
function are isolated resulting in decentralization of the SNS (39). The decrease in 
sympathetic modulation leads to changes in homeostatic maintenance of the CV 
system. The cardiac vagal fibers are spared following SCI, and their stimulation of 
cardiac structures is consequently unopposed (39), and prolonged periods of 
hypotension are common (39). In addition, medullary controls centers of the SNS are 
unable to maintain efferent control over vasomotor tone and function of the heart (39). 
The direct disruption of sympathetic pathways and the supraspinal control of those 
pathways ultimately lead to the dysregulation of HR, systolic and diastolic blood 
pressure, and vasoregulatory responses in daily routine situations (13)(22).  
After cervical and high thoracic SCI, patients experience daily bouts of 
hypertensive crisis due to the disruption of supraspinal control of SPGNs in the heart 
and surrounding vasculature (39)(40). The development of AD is most likely multifactorial, 
and involves the loss of bulbospinal regulation on SPGNs and aberrant reorganization 
and plasticity within lumbosacral circuitry (39).  Typically, episodes of AD are triggered via 




hypertensive episodes, accompanied by peripheral reflex-mediated bradycardia (39). An 
increase in BP is accompanied by reflex-mediated bradycardia which activates the 
PNS, releasing acetylcholine and decreasing HR. Importantly, if left untreated, AD may 
result in life-threatening consequences such as stroke or cardiomyocyte infarction (9)(41). 
The systolic blood pressure peaks common during bouts of AD in SCI patients 
are similar to what is noted in patients with chronic hypertension (41). Clinical 
hypertension diseases include concentric cardiac remodeling with preserved ejection 
fraction (EF) to dilated cardiac remodeling with reduced EF (20)(41). It has been 
suggested that chronic SCI patients experience concentric cardiac remodeling with 
reduced EF (29)(37). It is hypothesized that changes at the microscopic level, that is 
changes in cardiomyocytes, leads to changes at the macroscopic level. Spinal cord 
injury patients undergoing concentric remodeling, microscopically experience various 
kinase-signaling pathways that are characterized by contractile-proteins congregating 
into parallel units, leading to a decrease in sarcomere unit and in the length and width of 
individual cardiomyocytes (29)(38). As a result of cardiomyocyte stress, there is also an 
increase in LV wall thickness and decrease in LV diameter size during diastole and 
systole in hypotensive patients (37)(38). Concentric cardiac remodeling is also associated 
with hemodynamic cardiovascular changes, such as, decreased cardiac load from 
reduced blood volume, reduced sympathetic tone, and lack of skeletal-muscle pumps 
(29). Although the associated macroscopic and hemodynamic cardiovascular changes 
after SCI have been heavily studied, there is limited data on cardiomyocyte morphology. 





After SCI, the stimulation via SNS is decreased due to decentralization, therefore 
cardiac mass as well as arterial and venule tone is less maintained (37). Post spinal cord 
injury the body is in a hypotensive state, meaning systemic hypotension. In addition, 
there is OH and periods of AD that impact the cardiac cycle. The reduced sympathetic 
modulation leads to an upregulation of beta-adrenergic receptors or cardiomyocyte 
recruitment to combat systemic and orthostatic hypotension (37)(38). There are also intact 
spinal reflex mechanisms that trigger a life-threatening episodic hypertension crisis that 
disrupts the cardiac cycle. It is the balance between prolonged hypotension and 
episodic hypertension coupled with cardiac unloading that drives cardiomyocyte 
remodeling (42). 
  Physiologically, the body has negative feedback loops that combat 
cardiovascular dysfunction. An example of this is the beta-adrenergic stimulation. In all 
cardiomyocytes, B1-adrenergic receptors are present, being stimulated by 
norepinephrine (10). However, after SCI there is a decrease in norepinephrine due to 
SNS decentralization. Due to the decrease in norepinephrine, there is an upregulation 
of beta-adrenergic receptors or cardiomyocyte recruitment which leads to hyper-
responsive beta-adrenergic receptors that increase heart rate, stroke volume, and 
cardiac output (37)(38). After SCI, studies have demonstrated that B-adrenergic agonists 
and stimulators, dobutamine and norepinephrine, remain functional, bypassing 
disrupted sympathetic circuitry and acting directly on cardiac beta receptors (42). 
Dobutamine administration indicated that systolic function can be normalized with 
increased sympathetic stimulation due to an increase in HR, SV, and CO (42). Although 




cardiomyocyte health. Other major contributors to effects on cardiomyocyte remodeling 
post SCI is the level of the lesion.  
The level of the lesion impacts the number of intact descending sympatho-
excitatory axons which maintain sympathetic cardiovascular control (29).  Severe SCI 
patients experienced greater reduction in LV diameter in systole and diastole, radial 
strain, SV, and in cardiomyocyte length and width (29). Moderate SCI, typically below T6, 
experience similar afterload as severe SCI due to both injuries having similarly reduced 
BP. Therefore, it is hypothesized that afterload contributes less to the observed cardiac 
structural changes (29). Moderate SCI experience greater preservation of descending 
sympathetic pathways leading to more preserved contractile function, SV, and radial 
strain (29) than severe SCI. To further SCI treatment, a better understanding of moderate 
vs severe SCI, as well as, improving data on incomplete contusion models rather than 
completely transected models must take place. An area that has been heavily studied to 
improve SCI treatment is locomotion.  
Current SCI treatment focuses on further injury prevention. Patients are acutely 
bed ridden and wheelchair bound, as well as undergo robust cardiac decline and 
experience CVD more quickly (5)(42). The sudden physical inactivity of patients leads to 
chronic unloading associated with reduced skeletal muscle pumps, venous pooling, and 
overall cardiac decline. Therefore, movement maintains pre-load via muscle pumps, 
reduces the severity of autonomic dysreflexia, and positively impacts cardiac health 
(41)(42). Moving forward, researchers are expanding on the idea that movement can 
reduce cardiac decline and give a better blueprint to spinal cord injury treatment. For 




conveyed less reduction in systolic blood pressure and mean arterial pressure (42). 
Therefore, less cardiac decline, less impact on skeletal muscle pumps, less venous 
pooling, and lower overall cardiac decline were all observed in the study. In addition, 
passive hind limb cycling prevented myocardial fibrosis and improved blood lipid profiles 
(39)(41).  
There are still questions regarding the proper timing and intensity of exercise 
(41)(42). Everything in life is a balance, including spinal cord injury treatment and 
recovery. Finding that balance is one of the most difficult challenges. Although there 
have been hemodynamic improvements after implementation of passive-hind limb 
cycling (29)(38), the question of whether exercise will positively benefit cardiomyocyte 
morphology is still unknown. The processes associated with cardiac remodeling and the 
subsequent decline in CV health are complex; however, any new insights into how 
changes in cardiomyocyte morphology leads to cardiac demise in SCI patients help 
further SCI treatment and improve overall quality of life. 
In this study, female rats were used to quantify the incidence of cardiac 
remodeling after T2-SCI contusion. Although we did not find significant differences in 
cardiomyocyte morphology between T2-SCI and CON, Figure 1, (images A and B) 
conveyed visual representations of LV, IS, and RV similarly to past studies (37). In 
previous studies, T2-SCI, LV images seemed to represent less circular, wider 
cardiomyocytes that reduce the surface area to volume ratio making the cells less 
efficient. An increased collagen deposition and myocardial fibrosis indicate 
cardiomyocyte atrophy and reduction in contractility of the heart. Normally as shown in 




physiological components of healthy cardiac tissue. Therefore, the gaps in cardiac 
tissue after severe SCI is representative of the decrease of these collagen scaffolding 
proteins throughout cardiomyocyte remodeling. The decrease in the amount of 
sarcomeres due to cardiac unloading is hard to visibly see, yet relate to the decrease in 
strength of contraction in the heart. In comparison, the CON, LV, image seemed to 
represent more circular cardiomyocytes, less collagen deposition and myocardial 
fibrosis, more collagen scaffolding proteins, and more sarcomeres (37). Despite the lack 
of significant differences in this study, the images quantified seemed to trend toward 
agreeing with past studies that indicated T2-SCI undergoing concentric remodeling 
resulting in the most impacted sample, LV, demonstrating significant differences 
between T2-SCI and CON (37).  
The mean, maximum, and minimum area of T2-SCI and CON cardiomyocytes 
along with corresponding standard deviations are conveyed in Figure 1, (images 1Ci, 
1Cii, 1Ciii). Similarly, past data conveys an increase in overall cardiomyocyte area in 
T2-SCI (37). The T2-SCI, LV graph conveys no significant difference in mean, maximum, 
and minimum area. The increase in cardiomyocyte volume without chamber increase, 
accompanied by increased ventricular walls in LV after T2-SCI was expected. Past 
studies have demonstrated that atrophied hearts may have larger volumes, yet 
inversely proportional weight. Therefore, atrophied hearts have weaker contractions, 
increased stress, increased end-systolic and end-diastolic volumes, and increased pre-
load dependent oxygen demand leading to cardiovascular decline. More notable, the 
significantly different (p = .013) intra correlation conveys IS area larger than LV area in 




remodeling and mimic a more moderate-severe injury. The larger IS in CON may be 
due to the inactivity of the rodents. The inability to rear hindlimbs and get full myocardial 
contractions may reduce skeletal muscle pumps, reduce venous return, and lead to 
overall cardiovascular decline. As studies demonstrate that hindlimb exercise can 
reduce cardiac remodeling, prevent myocardial fibrosis, and improve blood lipid profiles 
(39), it may be plausible that a lack of movement, in post SCI and CON, leads to a 
reduction in LV cardiomyocyte function.  
The mean, maximum, and minimum shapefactor of T2-SCI and CON 
cardiomyocytes along with corresponding standard deviations are conveyed in Figure 2, 
(images 2Ai, 2Aii, 2Aiii). Similarly, past data conveys a decrease in overall 
cardiomyocyte shapefactor in T2-SCI (37). The T2-SCI, LV graph conveys no significant 
difference in mean, maximum, and minimum shapefactor. However, image 1Ai, conveys 
cardiomyocyte shapefactor RV mean approached significance, p = 0.053, between 
groups, T2-SCI and CON. The RV shapefactor significance is less notable than a 
significance between LV groups, T2-SCI and CON, due to physiological roles of the 
ventricles. After T2-SCI, cardiomyocyte morphology includes decreases in 
cardiomyocyte length and width which significantly correlate with decreased SV. The 
chronic unloading of cardiomyocytes after T2-SCI is correlated with the expected 









         Although the mechanisms linking SCI, cardiomyocyte remodeling, and the decline 
of CV health are still being elucidated, the presence of cardiomyocyte atrophy in rodents 
after severe SCI noted in conjunction with CV dysfunction is becoming universally 
accepted. The clinically-relevant contusion experiments designed facilitated an 
understanding of the relationships between LV, RV, and IS in relation to cardiomyocyte 
morphology. These correlations are important in understanding what is happening to the 
heart itself, in addition to orthostatic hypotension and autonomic dysreflexia. Future 
studies should examine multi-severity injuries to examine the correlations between 
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